Chris Farina
Comptroller/Controller/Auditor at Joyant Pharmaceuticals, Inc.
Network origin in Chris Farina first degree
Entity | Entity type | Industry | |
---|---|---|---|
Joyant Pharmaceuticals, Inc.
Joyant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Joyant Pharmaceuticals is a Dallas-based drug discovery company focused on the development of small molecule therapeutics for cancer. Their core competencies include chemical synthesis biochemistry, cell biology, and pharmacology. The focus of its company is on the development of unique chemical entities that operate by new cellular mechanisms. Its understanding of the molecular events that control the growth, replication, and apoptosis of human cells is becoming increasingly sophisticated. They intend to translate new knowledge of such pathways, and their misregulation in disease, into signaling-based targeted therapeutics.
3
| Private Company | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Chris Farina via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Yale University | College/University | Doctorate Degree | |
Skidmore College | College/University | Undergraduate Degree | |
Alfred P. Sloan Foundation
Alfred P. Sloan Foundation Miscellaneous Commercial ServicesCommercial Services Alfred P Sloan Foundation operates a non-profit organization. Its programs and interests are divided into five main areas as science & technology, standard of living & economic performance, education &careers in science & technology, selected national issues and the civic program. The foundation was established in 1934 and is headquartered in New York | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The University of Texas at Austin | College/University | Corporate Officer/Principal | |
Diazon Pharmaceuticals, Inc.
Diazon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diazon Pharmaceuticals, Inc. engages in the development of the onco-therapeutic DZ-2384 that targets a proven therapeutic pathway in oncology. The company was founded by Anne Roulston, Gordon Shore and Patrick Harran in 2013 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Founder |
Statistics
International
United States | 5 |
Canada | 2 |
Sectoral
Consumer Services | 4 |
Commercial Services | 2 |
Health Technology | 2 |
Operational
Corporate Officer/Principal | 3 |
Founder | 2 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Director of Finance/CFO | 1 |
Most connected contacts
Insiders | |
---|---|
Patrick G. Harran | 6 |
Donald Huffman | 1 |
Syed Ali | 1 |
- Stock Market
- Insiders
- Chris Farina
- Company connections